Crossmark

The Development of Epitope-Based Recombinant Protein Vaccines against SARS-CoV-2

Crossref DOI link: https://doi.org/10.1208/s12248-024-00963-1

Published Online: 2024-08-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Khalid, Kanwal

Lim, Hui Xuan

Hwang, Jung Shan

Poh, Chit Laa https://orcid.org/0000-0001-8475-6291
License Information

Text and Data Mining valid from 2024-08-13

Version of Record valid from 2024-08-13
More Information

Article History

Received: 22 May 2024

Accepted: 27 July 2024

First Online: 13 August 2024

Declarations

:

: The authors declare no conflict of interests.